Trending Now
A Starter Guide to Building Exposure to NFT Stocks for the...
One of the most remarkable growth opportunities to get in gear over the past year is the non-fungible token (NFT) marketplace. However,...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
ISWH Moves Towards Merging Telehealth And Crypto
An exciting conspiracy and an unexpected twist of events have led us to a renaissance in one industry, creating a potential opportunity for investors....
MAKE IT MODERN
LATEST REVIEWS
Vallon Pharmaceuticals Inc. (NASDAQ: VLON) Announce Topline Finding Results For Pivotal...
Vallon Pharmaceuticals Inc. (NASDAQ: VLON) has announced topline results from the pivotal SEAL study assessing ADAIR, a novel abuse-deterrent formula for immediate release dextroamphetamine...
MAKE IT MODERN
PERFORMANCE TRAINING
Ocugen Inc. (NASDAQ:OCGN) Announce Discontinuation Of Third Phase OCU300 Trial In Treatment of oGVHD
Ocugen Inc. (NASDAQ:OCGN) has announced that it has decided to stop the third phase OCU300 trials for ocular Graft versus Host Disease (oGVHD).
Ocugen discontinues...
US FDA Accepts Ocugen Inc.’s (NASDAQ: OCGN) Investigational New Drug Application TO commence Phase...
Ocugen Inc. (NASDAQ: OCGN) has announced that the FDA has cleared its Investigational New Drug application to commence the first-in-human study of OCU400, a...
Emerging Themes in the COVID-19 Vaccine Space (MRNA, PFE, DYAI, JNJ, NVAX, BNTX, AZN)
Pfizer and its partner, BioNTech, announced a few days ago that they plan to ask U.S. and European regulators to authorize a...
Stocks Rise as OPEX week comes to an end (PERI, AMZN)
Futures are slightly red this morning seemingly on a gap down it seems in AAPL (-1.45%) although not seeing news on that. ...
Atara Biotherapeutics (ATRA) Secures Strategic Investments to Advance T-cell Immunotherapy Innovations
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, has announced a significant new phase of financing to boost its development...
MAKE IT MODERN
